Testing effectiveness (Phase 2)Study completedNCT01059383
What this trial is testing
Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms
Who this might be right for
Gastroesophageal Reflux
Vecta Ltd. 52